Hayzer Pharma Private Limited
About Hayzer Pharma Private Limited
Data last updated:
Hayzer Pharma Private Limited is a private limited company based in Delhi, India. It operates in the meat processing and preservation segment of the food and beverages sector. It was incorporated on 28 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U15100DL2020PTC365319.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Nilo Dairy Food Private Limited. It is led by directors including Sarfaraz Hussain and Neelofar Hussain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 42 P No.304 Top Floor Gali No.15 Madhu Vihar, Delhi, India – 110092.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – 42 P No.304 Top Floor Gali No.15 Madhu Vihar, Delhi, India – 110092
- IndustryFood And Beverages, Processing And Preservation Of Meat, Fish, Fruit Vegetables
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Hayzer Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Hayzer Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hayzer Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hayzer Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Hayzer Pharma Private Limited
Hayzer Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarfaraz Hussain | Director | 10 Jun 2024 | 2 Years 3 Months | Current |
| Neelofar Hussain Also directs: Nankana Food Private Limited | Director | 28 Jun 2020 | 6 Years 3 Months | Current |
| Rahil Hussain | Director | 28 Jun 2020 | 6 Years 3 Months | Current |
Charges & Borrowings of Hayzer Pharma Private Limited
Hayzer Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Hayzer Pharma Private Limited
Employment history and EPFO contributions of people linked to Hayzer Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Hayzer Pharma Private Limited
Hayzer Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U15100DL2020PTC365319, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U15100DL2020PTC365319 | Current |
| U74110DL2020PTC365319 | Previous |
| U15204DL2020PTC365319 | Previous |
Recent Activity on Hayzer Pharma Private Limited
Hayzer Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Sarfaraz Hussain was appointed as Director on 10 Jun 2024.
Credit Ratings, Litigation & Regulatory Alerts for Hayzer Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hayzer Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hayzer Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hayzer Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hayzer Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hayzer Pharma Private Limited
Hayzer Pharma is an active private limited company based in Delhi, India. The company works in processing and preservation of meat, within the food and beverages industry. It was incorporated on 28 June 2020 (6+ years old) and is registered under CIN U15100DL2020PTC365319.
Hayzer Pharma has 3 current directors:
- Sarfaraz Hussain - Director
- Neelofar Hussain - Director
- Rahil Hussain - Director
The CIN (Corporate Identification Number) of Hayzer Pharma is U15100DL2020PTC365319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hayzer Pharma was incorporated on 28 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Sarfaraz Hussain was appointed as Director on 10 Jun 2024. Neelofar Hussain was appointed as Director on 28 Jun 2020. Rahil Hussain was appointed as Director on 28 Jun 2020.
The registered office of Hayzer Pharma is at E – 42 P No.304 Top Floor Gali No.15 Madhu Vihar, Delhi, India – 110092.
Hayzer Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Hayzer Pharma operates in the food and beverages industry, in the processing and preservation of meat segment.
No. Hayzer Pharma is not listed on any stock exchange. It is an unlisted company.
Yes. Hayzer Pharma was formerly known as Nilo Dairy Food Private Limited.